RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.


Leading behavioral health and opioid expert joins RTI International

RESEARCH TRIANGLE PARK, NC— Kevin Conway, Ph.D., an expert in how behavioral health relates to substance use, has joined RTI as a senior behavioral health scientist.

Previously a deputy director at the National Institute on Drug Abuse (NIDA), Conway is responsible for helping shape strategic planning and business development in substance use and behavioral health research areas at RTI.

“I wanted to join a mission-focused research organization that fosters bold ideas, creativity, and visionary leadership to improve public health,” said Conway on why he chose RTI. “RTI offered it all, including a highly collegial environment and an impressive track record of success.”

At NIDA, where Conway worked for 16 years, he held several leadership positions including deputy director of the Division of Epidemiology, Services, and Prevention Research. While there, he helped lead the Population Assessment of Tobacco and Health Study and the Adolescent Cognitive Development Study.

“Dr. Conway’s experience is uniquely suited for RTI as we continue to provide policy makers and private industry with the most up-to-date research on substance use and the ongoing opioid epidemic,” said Heather Ringeisen, Ph.D., director of RTI’s Survey Research Division’s Center for Behavioral Health and Development. “He has more than a decade of experience researching behavioral health and how it relates to alcohol, tobacco and drug use and brings extensive expertise in identifying scientific topics in need of strategic development.”

Conway has authored more than 70 peer-reviewed articles and book chapters focused on the epidemiology of alcohol, tobacco, drug use, co-occurring psychiatric disorders, and violence. He is also a Fellow of the American Psychopathological Association, and the recipient of numerous awards for leadership in research, including the National Institutes of Health’s Director’s Award of Merit and the NIDA Director’s Award of Merit.

Conway holds a doctorate degree in experimental psychology and a master’s degree in psychology from Temple University, and received postdoctoral training in psychiatric and genetic epidemiology at Yale University. He received his bachelor’s degree from St. Louis University.  



About RTI International

RTI International is an independent, nonprofit research institute dedicated to improving the human condition. Clients rely on us to answer questions that demand an objective and multidisciplinary approach—one that integrates expertise across the social and laboratory sciences, engineering, and international development. We believe in the promise of science, and we are inspired every day to deliver on that promise for the good of people, communities, and businesses around the world. For more information, visit www.rti.org